Generation of a Nebulizable CDR-Modified MERS-CoV Neutralizing Human Antibody
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Generation of a Nebulizable CDR-Modified MERS-CoV Neutralizing Human Antibody
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 20, Issue 20, Pages 5073
Publisher
MDPI AG
Online
2019-10-14
DOI
10.3390/ijms20205073
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- High-throughput retrieval of physical DNA for NGS-identifiable clones in phage display library
- (2019) Jinsung Noh et al. mAbs
- Delivery of ALX-0171 by inhalation greatly reduces respiratory syncytial virus disease in newborn lambs
- (2018) Alejandro Larios Mora et al. mAbs
- Middle East respiratory syndrome: what we learned from the 2015 outbreak in the Republic of Korea
- (2018) Myoung-don Oh et al. KOREAN JOURNAL OF INTERNAL MEDICINE
- A Role for Fc Function in Therapeutic Monoclonal Antibody-Mediated Protection against Ebola Virus
- (2018) Bronwyn M. Gunn et al. Cell Host & Microbe
- A Human DPP4-Knockin Mouse’s Susceptibility to Infection by Authentic and Pseudotyped MERS-CoV
- (2018) Changfa Fan et al. Viruses-Basel
- Nanobodies® † †Nanobody is a registered trademark of Ablynx NV. as inhaled biotherapeutics for lung diseases
- (2017) Gino Van Heeke et al. PHARMACOLOGY & THERAPEUTICS
- Mouse-adapted MERS coronavirus causes lethal lung disease in human DPP4 knockin mice
- (2017) Kun Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Rapid and accurate in silico solubility screening of a monoclonal antibody library
- (2017) Pietro Sormanni et al. Scientific Reports
- Single-dose treatment with a humanized neutralizing antibody affords full protection of a human transgenic mouse model from lethal Middle East respiratory syndrome (MERS)-coronavirus infection
- (2016) Hongjie Qiu et al. ANTIVIRAL RESEARCH
- MERS-CoV spike protein: a key target for antivirals
- (2016) Lanying Du et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Prophylaxis With a Middle East Respiratory Syndrome Coronavirus (MERS-CoV)–Specific Human Monoclonal Antibody Protects Rabbits From MERS-CoV Infection
- (2016) Katherine V. Houser et al. JOURNAL OF INFECTIOUS DISEASES
- Immunogenicity of Therapeutic Protein Aggregates
- (2016) Ehab M. Moussa et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Viral Load Kinetics of MERS Coronavirus Infection
- (2016) Myoung-don Oh et al. NEW ENGLAND JOURNAL OF MEDICINE
- Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody
- (2016) D. Corti et al. SCIENCE
- Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivo
- (2016) Thomas Luke et al. Science Translational Medicine
- 3B11-N, a monoclonal antibody against MERS-CoV, reduces lung pathology in rhesus monkeys following intratracheal inoculation of MERS-CoV Jordan-n3/2012
- (2016) Reed F. Johnson et al. VIROLOGY
- Passive Transfer of A Germline-like Neutralizing Human Monoclonal Antibody Protects Transgenic Mice Against Lethal Middle East Respiratory Syndrome Coronavirus Infection
- (2016) Anurodh Shankar Agrawal et al. Scientific Reports
- A mouse model for MERS coronavirus-induced acute respiratory distress syndrome
- (2016) Adam S. Cockrell et al. Nature Microbiology
- A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein
- (2015) Yan Li et al. CELL RESEARCH
- Development and Evaluation of Novel Real-Time Reverse Transcription-PCR Assays with Locked Nucleic Acid Probes Targeting Leader Sequences of Human-Pathogenic Coronaviruses
- (2015) Jasper Fuk-Woo Chan et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Middle East Respiratory Syndrome Coronavirus Causes Multiple Organ Damage and Lethal Disease in Mice Transgenic for Human Dipeptidyl Peptidase 4
- (2015) Kun Li et al. JOURNAL OF INFECTIOUS DISEASES
- Generation of a Transgenic Mouse Model of Middle East Respiratory Syndrome Coronavirus Infection and Disease
- (2015) Anurodh Shankar Agrawal et al. JOURNAL OF VIROLOGY
- Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus
- (2015) Davide Corti et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection
- (2015) Kristen E. Pascal et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Junctional and allele-specific residues are critical for MERS-CoV neutralization by an exceptionally potent germline-like antibody
- (2015) Tianlei Ying et al. Nature Communications
- Multi-Organ Damage in Human Dipeptidyl Peptidase 4 Transgenic Mice Infected with Middle East Respiratory Syndrome-Coronavirus
- (2015) Guangyu Zhao et al. PLoS One
- Fate of inhaled monoclonal antibodies after the deposition of aerosolized particles in the respiratory system
- (2014) L. Guilleminault et al. JOURNAL OF CONTROLLED RELEASE
- Exceptionally Potent Neutralization of Middle East Respiratory Syndrome Coronavirus by Human Monoclonal Antibodies
- (2014) Tianlei Ying et al. JOURNAL OF VIROLOGY
- A Conformation-Dependent Neutralizing Monoclonal Antibody Specifically Targeting Receptor-Binding Domain in Middle East Respiratory Syndrome Coronavirus Spike Protein
- (2014) L. Du et al. JOURNAL OF VIROLOGY
- Effect of formulation on the stability and aerosol performance of a nebulized antibody
- (2014) Renaud Respaud et al. mAbs
- A promoter-level mammalian expression atlas
- (2014) NATURE
- Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution
- (2014) X.-C. Tang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Potent Neutralization of MERS-CoV by Human Neutralizing Monoclonal Antibodies to the Viral Spike Glycoprotein
- (2014) L. Jiang et al. Science Translational Medicine
- Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4
- (2013) Nianshuang Wang et al. CELL RESEARCH
- The emerging novel Middle East respiratory syndrome coronavirus: The “knowns” and “unknowns”
- (2013) Jasper Fuk-Woo Chan et al. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
- Human Cell Tropism and Innate Immune System Interactions of Human Respiratory Coronavirus EMC Compared to Those of Severe Acute Respiratory Syndrome Coronavirus
- (2013) F. Zielecki et al. JOURNAL OF VIROLOGY
- Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission
- (2013) Benoit Guery et al. LANCET
- Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
- (2013) V. Stalin Raj et al. NATURE
- Efficient Replication of the Novel Human Betacoronavirus EMC on Primary Human Epithelium Highlights Its Zoonotic Potential
- (2013) E. Kindler et al. mBio
- Impact of lyoprotectants for the stabilization of biodegradable nanoparticles on the performance of air-jet, ultrasonic, and vibrating-mesh nebulizers
- (2012) Moritz Beck-Broichsitter et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- An Antibody to the Sixth Ig-like Domain of VCAM-1 Inhibits Leukocyte Transendothelial Migration without Affecting Adhesion
- (2012) Sukmook Lee et al. JOURNAL OF IMMUNOLOGY
- Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
- (2012) Ali M. Zaki et al. NEW ENGLAND JOURNAL OF MEDICINE
- General strategy for the generation of human antibody variable domains with increased aggregation resistance
- (2012) K. Dudgeon et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Genomic Characterization of a Newly Discovered Coronavirus Associated with Acute Respiratory Distress Syndrome in Humans
- (2012) S. van Boheemen et al. mBio
- Mutational analysis of domain antibodies reveals aggregation hotspots within and near the complementarity determining regions
- (2011) Joseph M. Perchiacca et al. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
- Potential aggregation prone regions in biotherapeutics
- (2010) Xiaoling Wang et al. mAbs
- Structure-based engineering of a monoclonal antibody for improved solubility
- (2010) S.-J. Wu et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Reduced elimination of IgG antibodies by engineering the variable region
- (2010) T. Igawa et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Design of therapeutic proteins with enhanced stability
- (2009) N. Chennamsetty et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The influence of the framework core residues on the biophysical properties of immunoglobulin heavy chain variable domains
- (2009) Annemarie Honegger et al. PROTEIN ENGINEERING DESIGN & SELECTION
- How antibodies fold
- (2009) Matthias J. Feige et al. TRENDS IN BIOCHEMICAL SCIENCES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More